| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9643780 | Journal of the American Academy of Child & Adolescent Psychiatry | 2005 | 7 Pages |
Abstract
These preliminary findings, occurring at doses low by current treatment standards, suggest that close electrocardiographic monitoring is warranted when prescribing ziprasidone to children, particularly at higher doses or when combined with other QTc-prolonging agents.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
JENNIFER B.S., LAWRENCE M.S.N., MATTHEW M.D., ANDRÃS M.D., M.P.H.,